Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Baqar

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1990
Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapyJ R Murphy, D F Clyde, D A Herrington, et al.
Clinical and Experimental Immunology|February 1, 1989
Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regionsJ R Murphy, S S Wasserman, S Baqar, et al.
The American Journal of Tropical Medicine and Hygiene|February 1, 1989
Estimate of Plasmodium falciparum sporozoite content of Anopheles stephensi used to challenge human volunteersJ R Davis, J R Murphy, D F Clyde, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1993
Activation and enhanced contact of human T-lymphocytes with autologous red blood cells are required for their stable adherence at 37 degreesT Khavkin, M Kuchler, M Carl, et al.
Infection and Immunity|December 1, 1996
Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunityS Baqar, A L Bourgeois, L A Applebee, et al.
Vaccine|January 1, 1995
Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primatesS Baqar, A L Bourgeois, P J Schultheiss, et al.
Tropical and Geographical Medicine|April 1, 1988
A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccinesD A Herrington, D F Clyde, J R Murphy, et al.
Vaccine|May 21, 2011
Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infectionS Barnoy, S Baqar, R W Kaminski, et al.
Vaccine|February 14, 2014
Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypesR T Ranallo, R Kaminski, S Baqar, et al.
Infection and Immunity|October 26, 1999
Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuniL H Lee, E Burg, S Baqar, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|April 1, 1990
Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapyJ R Murphy, D F Clyde, D A Herrington, et al.
Clinical and Experimental Immunology|February 1, 1989
Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regionsJ R Murphy, S S Wasserman, S Baqar, et al.
The American Journal of Tropical Medicine and Hygiene|February 1, 1989
Estimate of Plasmodium falciparum sporozoite content of Anopheles stephensi used to challenge human volunteersJ R Davis, J R Murphy, D F Clyde, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1993
Activation and enhanced contact of human T-lymphocytes with autologous red blood cells are required for their stable adherence at 37 degreesT Khavkin, M Kuchler, M Carl, et al.
Infection and Immunity|December 1, 1996
Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunityS Baqar, A L Bourgeois, L A Applebee, et al.
Vaccine|January 1, 1995
Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primatesS Baqar, A L Bourgeois, P J Schultheiss, et al.
Tropical and Geographical Medicine|April 1, 1988
A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccinesD A Herrington, D F Clyde, J R Murphy, et al.
Vaccine|May 21, 2011
Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infectionS Barnoy, S Baqar, R W Kaminski, et al.
Vaccine|February 14, 2014
Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypesR T Ranallo, R Kaminski, S Baqar, et al.
Infection and Immunity|October 26, 1999
Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuniL H Lee, E Burg, S Baqar, et al.
Pageof 5